These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 2574910

  • 1. Omeprazole in the management of refractory duodenal ulcer.
    Bardhan KD.
    Scand J Gastroenterol Suppl; 1989; 166():63-73. PubMed ID: 2574910
    [Abstract] [Full Text] [Related]

  • 2. Is there any acid peptic disease that is refractory to proton pump inhibitors?
    Bardhan KD.
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():13-24, discussion 29-31. PubMed ID: 8490075
    [Abstract] [Full Text] [Related]

  • 3. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
    Bardhan KD, Naesdal J, Bianchi Porro G, Petrillo M, Lazzaroni M, Hinchliffe RF, Thompson M, Morris P, Daly MJ, Carroll NJ.
    Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
    [Abstract] [Full Text] [Related]

  • 4. Medical therapy of peptic ulcer disease.
    McQuaid KR, Isenberg JI.
    Surg Clin North Am; 1992 Apr; 72(2):285-316. PubMed ID: 1347960
    [Abstract] [Full Text] [Related]

  • 5. The clinical utility and safety of omeprazole.
    Walan A.
    Scand J Gastroenterol Suppl; 1989 Apr; 166():140-4; discussion 145. PubMed ID: 2574908
    [Abstract] [Full Text] [Related]

  • 6. Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists.
    Tytgat GN, Lamers CB, Hameeteman W, Jansen JM, Wilson JA.
    Aliment Pharmacol Ther; 1987 Feb; 1(1):31-8. PubMed ID: 2908747
    [Abstract] [Full Text] [Related]

  • 7. Relationship between inhibition of acid secretion and healing of peptic ulcers.
    Chiverton SG, Hunt RH.
    Scand J Gastroenterol Suppl; 1989 Feb; 166():43-7; discussion 74-5. PubMed ID: 2690331
    [Abstract] [Full Text] [Related]

  • 8. Irradiation-induced duodenal ulcer disease refractory to ranitidine: healing by omeprazole.
    Koop H, Koop I, Klein M, Stumpf M, Massarrat S, Arnold R.
    J Clin Gastroenterol; 1989 Dec; 11(6):631-4. PubMed ID: 2573627
    [Abstract] [Full Text] [Related]

  • 9. Omeprazole in the treatment of duodenal ulcer.
    Bianchi Porro G, Parente F.
    Scand J Gastroenterol Suppl; 1989 Dec; 166():48-53; discussion 74-5. PubMed ID: 2557670
    [Abstract] [Full Text] [Related]

  • 10. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.
    Wilde MI, McTavish D.
    Drugs; 1994 Jul; 48(1):91-132. PubMed ID: 7525198
    [Abstract] [Full Text] [Related]

  • 11. Idiopathic gastric acid hypersecretion: treatment implications for refractory acid/peptic disorders.
    Lewis JH.
    Aliment Pharmacol Ther; 1991 Jul; 5 Suppl 1():15-24. PubMed ID: 1888834
    [Abstract] [Full Text] [Related]

  • 12. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD, Cherian P, Jones RB, Vaishnavi A, Manek S, Bishop A, Polak J, Brooks A, Morris P, Thompson M, D'Silva J, Parkin S, Patterson J, Gillon KR.
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
    [Abstract] [Full Text] [Related]

  • 13. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Dec; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 14. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S, Långström G, Rikner L, Carlsson R, Naesdal J.
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [Abstract] [Full Text] [Related]

  • 15. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
    McTavish D, Buckley MM, Heel RC.
    Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
    [Abstract] [Full Text] [Related]

  • 16. Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer.
    Catalano F, Catanzaro R, Bentivegna C, Brogna A, Condorelli G, Cipolla R.
    Aliment Pharmacol Ther; 1998 Jan; 12(1):59-62. PubMed ID: 9692702
    [Abstract] [Full Text] [Related]

  • 17. [Omeprazole in the therapy of acid-induced diseases].
    Simon B, Dammann HG, Müller P.
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
    [Abstract] [Full Text] [Related]

  • 18. Omeprazole and ranitidine in long-term treatment of duodenal ulcer: a double-blind comparison of length of time in remission.
    Diaz de Rojas F, Berenguer J, Rodrigo L, Aran-Suau R, Da Silveira JC, Clerch L, Garcia Aparicio P, Caswell C.
    Dig Dis Sci; 1998 Sep; 43(9):1964-9. PubMed ID: 9753259
    [Abstract] [Full Text] [Related]

  • 19. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T, Lemaire M, Agostini H.
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [Abstract] [Full Text] [Related]

  • 20. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1999 Jul; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.